Xoma reported $7.7M in Operating Expenses for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbvie ABBV:US USD 9.62B 590M
Agenus AGEN:US USD 88.08M 23.66M
Agios Pharmaceuticals AGIO:US USD -24371000 114.53M
Ardelyx ARDX:US USD 32.03M 5.17M
Biomarin Pharmaceutical BMRN:US USD 562.04M 54.28M
Bluebird Bio BLUE:US USD 84.85M 24.07M
Celldex Therapeutics CLDX:US USD 29.5M 1.4M
Chimerix CMRX:US USD 24.63M 3.72M
Curis CRIS:US USD 13.11M 2.32M
Eli Lilly And LLY:US USD 5.47B 200.3M
Emergent Biosolutions EBS:US USD 395.8M 113.8M
Intercept Pharmaceuticals ICPT:US USD 95.24M 84.25M
Life Technologies LIFE:US USD 18.34M 4.84M
Macrogenics MGNX:US USD 61.12M 5.57M
Novartis NOVN:VX USD 11.05B 378M
Novartis NVS:US USD 11.05B 378M
Pfizer PFE:US USD 19.12B 5.9B
Prothena PRTA:US USD 50M 1.85M
Regeneron Pharmaceuticals REGN:US USD 2.27B 555.1M
Teva Pharmaceutical Industries TEVA:US USD 4.74B 1.56B
Xoma XOMA:US USD 7.7M 2.87M
YTE INCY:US USD 856.61M 171.68M